Radiation Dose From Computed Tomography Before and After Implementation of a High Pitch Dual Spiral Technique
NCT ID: NCT01111760
Last Updated: 2013-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
334 participants
OBSERVATIONAL
2010-05-31
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
On Dose Efficiency of Modern CT-scanners in Chest Scans
NCT04996693
Breast Displacement and CT Radiation Dose
NCT01261559
Dose Reduction in Thoracic CT
NCT00188461
Perfusion Imaging and CT -Understanding Relative Efficacy
NCT00486447
320-slice Coronary Computed Tomography (CT) Angiography
NCT00721851
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recent major technological advances have been made with the advent of newer generation CT scanners which allow significant radiation dose reduction. One such scanner, the dual source CT, is a new high pitch dual source spiral technique that offers the ability to image a patient's chest with ECG gated imaging protocols within a single second. These technological advances allow significant radiation dose savings, often resulting in effective radiation doses of less than one millisievert (mSv).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Michael Gallagher
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Gallagher
Cardiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Gallagher, MD
Role: PRINCIPAL_INVESTIGATOR
William Beaumont Hospitals
Gilbert Raff, MD
Role: STUDY_DIRECTOR
William Beaumont Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
William Beaumont Hospital-Royal Oak
Royal Oak, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HIC 2010-082
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.